Momneed cap, 1 strip

Momneed cap, 1 strip

DESCRIPTION

Momneed is a preparation of vitamins and minerals. It is composed of elemental iron (as carbonyl iron), folic acid, zinc sulfate monohydrate, vitamin C (as ascorbic acid), thiamine mononitrate, riboflavin, pyridoxine hydrochloride and nicotinamide. Iron is present as carbonyl iron to avoid gastric irritation and to avoid toxicity which possesses higher bioavailability.

COMPOSITION

Each capsule contains :

Elemental iron (as carbonyl iron) INN 50 mg

Folic acid BP 0.5 mg

Zinc sulfate monohydrate USP 61.8 mg

Vitamin C (as ascorbic acid) BP 50 mg

Thiamine mononitrate BP 2 mg

Riboflavin BP 2 mg

Pyridoxine hydrochloride BP 1 mg

Nicotinamide BP 10 mg

INDICATIONS

Momneed is indicated for :

 Pregnant women

 Lactating mothers

 Women with heavy menstrual bleeding

 Geriatric patients

 Generalized weakness due to vitamins and minerals deficiency.

DOSAGE AND ADMINISTRATION

Adult : One capsule daily before meal.

OR AS DIRECTED BY THE PHYSICIAN.

SIDE EFFECTS

Allergic sensitization has been reported following oral administration of folic acid. Oral iron preparation may cause constipation particularly in older patients, occasionally leading to fecal impaction.

CONTRAINDICATIONS

It is contraindicated in patients with known hypersensitivity to any of the ingredients. Iron therapy is contraindicated in the presence of hemolytic anaemia.

PRECAUTIONS

Special care should be taken in patient with iron overload states, such as heaemochromatosis, hemolytic anaemia or red cell aplasia. In patients with renal failure there may be the risk of zinc accumulation.

USE IN PREGNANCY AND LACTATION

Recommended.

DRUG INTERACTIONS

Folic acid interacts with antiepileptic drugs, no plasma concentrations of phenobarbital, phenytoin possibly reduced. Iron may decrease the absorption of antacids, tetracycline, quinolone antibiotics, levodopa, levothyroxine, methyldopa and penicillamine.

OVERDOSAGE

Symptoms of overdose with iron include epigastric pain, nausea and vomiting,

Hematemesis and circulatory collapse. In severe cases encephalopathy, acute hepatic necrosis and renal failure may develop after a latent period. Treatment consists of gastric lavage followed by the introduction of 5 gm Desferrioxamine into the stomach.

Serum iron levels should be monitored; in severe cases intravenous Desferrioxamine should be given together with supportive and symptomatic measures as required.

SUPPLY

Each box contains 5 x 10 capsules in Alu-PVC/PVDC blister strips.